View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsEnphys Acquisition 配当と自社株買い配当金 基準チェック /06Enphys Acquisition配当金を支払った記録がありません。主要情報n/a配当利回り241.9%バイバック利回り総株主利回り241.9%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Dec 31Enphys Acquisition Corp. Units, Each Consisting of One Class A Ordinary Share and One-Half of One Redeemable Warrant Deleted from OTC EquityEnphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant has been deleted from OTC Equity effective December 30, 2024, due to Unit Separation.お知らせ • Nov 15Enphys Acquisition Corp. Files Form 15Enphys Acquisition Corp. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant; Class A ordinary shares included as part of the Units, par value $0.0001 per share and Redeemable warrants included as part of the Units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share under the Securities Exchange Act of 1934, as amended.お知らせ • Oct 17The Staff of NYSE Regulation Files Form 25 with the SEC to Remove Enphys Acquisition's Class A Ordinary Shares, Units from Listing and Registration on the New York Stock ExchangeAs previously reported by Enphys Acquisition Corp. (the ‘Company’), on July 24, 2024, the staff of NYSE Regulation (the ‘Staff’), on behalf of the New York Stock Exchange (‘NYSE’), commenced proceedings to delist the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A Ordinary Shares’), units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant (the ‘Units’), with each warrant exercisable for one share of Class A Ordinary Share of the Company (the ‘Warrants’), and Warrants from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. Trading in the Class A Ordinary Shares, Units, and Warrants on the NYSE was suspended after the market closed on July 24, 2024. Effective as of and since July 25, 2024, the Class A Ordinary Shares, Units, and Warrants have been quoted and traded on the OTC Pink Marketplace under the ticker symbols ‘NFSCF,’ ‘NFSUF,’ and ‘NFSWF,’ respectively. The Company timely exercised its right to a review of the Staff’s determination by a committee (the ‘Committee’) of the Board of Directors of the NYSE. On October 10, 2024, the Company withdrew its request for review by the Committee. On October 10, 2024, the Staff filed a Form 25 with the Securities and Exchange Commission (the ‘SEC’) to remove the Company’s Class A Ordinary Shares, Units, and Warrants from listing and registration on the NYSE. The delisting will be effective 10 days following the date of filing of the Form 25. The Company’s Class A Ordinary Shares, Units, and Warrants will continue to trade on the OTC Pink Marketplace following the delisting.お知らせ • Aug 14Enphys Acquisition Corp. announced delayed 10-Q filingOn 08/13/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 26NYSE to Commence Delisting Proceedings Against Enphys AcquisitionThe New York Stock Exchange LLC announced that the staff of NYSE Regulation has determined to commence proceedings to delist Class A ordinary shares, par value 0.0001 per share; Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant and Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary shares at an exercise price of 11.50 of Enphys Acquisition Corp. (the “Company”) from the NYSE. Trading in the Company’s Securities will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.お知らせ • May 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 02Enphys Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 11/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Oct 31Enphys Acquisition Corp. announced that it has received $0.3 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $300,000 on October 30, 2023. The issuance of the Promissory Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Under the terms of the promissory note, the company may request from time to time prior to the maturity date, up to $300,000 in drawdowns on the principal. Each drawdown request must state the amount to be drawn down, and must not be an amount less than $10,000 unless agreed upon by the company and the payee. Payee shall fund each drawdown request no later than (3) business days after receipt of a drawdown request; provided, however, that the maximum amount of drawdowns outstanding under the promissory note at any time may not exceed $300,000. No fees, payments or other amounts shall be due to the payee in connection with, or as a result of, any drawdown request by the company.お知らせ • Oct 11Enphys Acquisition Corp. announced that it expects to receive $0.4 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $400,000 on October 10, 2023. Payee or one or more of its affiliates or designees will deposit into the company’s trust account established in connection with its initial public offering an amount equal to the lesser of $0.025 per Class A ordinary share of the company multiplied by the number of Class A ordinary shares of the Company then outstanding and $100,000, for each calendar month until the earlier of the company’s completion of a business combination and February 8, 2024. No interest shall be payable on this note.お知らせ • May 16Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.決済の安定と成長配当データの取得安定した配当: NFSU.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: NFSU.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Enphys Acquisition 配当利回り対市場NFSU.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (NFSU.F)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Capital Markets)2.1%アナリスト予想 (NFSU.F) (最長3年)n/a注目すべき配当: NFSU.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: NFSU.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: NFSU.Fの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: NFSU.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/12/31 16:18終値2024/12/17 00:00収益2024/06/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Enphys Acquisition Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Dec 31Enphys Acquisition Corp. Units, Each Consisting of One Class A Ordinary Share and One-Half of One Redeemable Warrant Deleted from OTC EquityEnphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant has been deleted from OTC Equity effective December 30, 2024, due to Unit Separation.
お知らせ • Nov 15Enphys Acquisition Corp. Files Form 15Enphys Acquisition Corp. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant; Class A ordinary shares included as part of the Units, par value $0.0001 per share and Redeemable warrants included as part of the Units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share under the Securities Exchange Act of 1934, as amended.
お知らせ • Oct 17The Staff of NYSE Regulation Files Form 25 with the SEC to Remove Enphys Acquisition's Class A Ordinary Shares, Units from Listing and Registration on the New York Stock ExchangeAs previously reported by Enphys Acquisition Corp. (the ‘Company’), on July 24, 2024, the staff of NYSE Regulation (the ‘Staff’), on behalf of the New York Stock Exchange (‘NYSE’), commenced proceedings to delist the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A Ordinary Shares’), units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant (the ‘Units’), with each warrant exercisable for one share of Class A Ordinary Share of the Company (the ‘Warrants’), and Warrants from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. Trading in the Class A Ordinary Shares, Units, and Warrants on the NYSE was suspended after the market closed on July 24, 2024. Effective as of and since July 25, 2024, the Class A Ordinary Shares, Units, and Warrants have been quoted and traded on the OTC Pink Marketplace under the ticker symbols ‘NFSCF,’ ‘NFSUF,’ and ‘NFSWF,’ respectively. The Company timely exercised its right to a review of the Staff’s determination by a committee (the ‘Committee’) of the Board of Directors of the NYSE. On October 10, 2024, the Company withdrew its request for review by the Committee. On October 10, 2024, the Staff filed a Form 25 with the Securities and Exchange Commission (the ‘SEC’) to remove the Company’s Class A Ordinary Shares, Units, and Warrants from listing and registration on the NYSE. The delisting will be effective 10 days following the date of filing of the Form 25. The Company’s Class A Ordinary Shares, Units, and Warrants will continue to trade on the OTC Pink Marketplace following the delisting.
お知らせ • Aug 14Enphys Acquisition Corp. announced delayed 10-Q filingOn 08/13/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 26NYSE to Commence Delisting Proceedings Against Enphys AcquisitionThe New York Stock Exchange LLC announced that the staff of NYSE Regulation has determined to commence proceedings to delist Class A ordinary shares, par value 0.0001 per share; Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant and Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary shares at an exercise price of 11.50 of Enphys Acquisition Corp. (the “Company”) from the NYSE. Trading in the Company’s Securities will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
お知らせ • May 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 02Enphys Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 11/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Oct 31Enphys Acquisition Corp. announced that it has received $0.3 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $300,000 on October 30, 2023. The issuance of the Promissory Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Under the terms of the promissory note, the company may request from time to time prior to the maturity date, up to $300,000 in drawdowns on the principal. Each drawdown request must state the amount to be drawn down, and must not be an amount less than $10,000 unless agreed upon by the company and the payee. Payee shall fund each drawdown request no later than (3) business days after receipt of a drawdown request; provided, however, that the maximum amount of drawdowns outstanding under the promissory note at any time may not exceed $300,000. No fees, payments or other amounts shall be due to the payee in connection with, or as a result of, any drawdown request by the company.
お知らせ • Oct 11Enphys Acquisition Corp. announced that it expects to receive $0.4 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $400,000 on October 10, 2023. Payee or one or more of its affiliates or designees will deposit into the company’s trust account established in connection with its initial public offering an amount equal to the lesser of $0.025 per Class A ordinary share of the company multiplied by the number of Class A ordinary shares of the Company then outstanding and $100,000, for each calendar month until the earlier of the company’s completion of a business combination and February 8, 2024. No interest shall be payable on this note.
お知らせ • May 16Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.